Herein, in order to improve cell response to BRAF inhibitor treatment, attenuation of the PIK3CAH1047 that co-exist with BRAFV600E in the relevant colon cancer cell lines was performed. The gene discussed is BRAF; the disease is malignant colon neoplasm.